| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/05/2009 | WO2009017833A2 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 02/05/2009 | WO2009017736A1 Diagnostic assay for trypanosoma cruzi infection |
| 02/05/2009 | WO2009017689A2 Methods for detection and prevention of tick infestation and pathogen transmission |
| 02/05/2009 | WO2009017666A1 Capsule composition for use as immunogen against campylobacter jejuni |
| 02/05/2009 | WO2009017620A1 Chemokine analogs |
| 02/05/2009 | WO2009017467A1 Treatment of amyloidogenic diseases |
| 02/05/2009 | WO2009017456A1 Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes |
| 02/05/2009 | WO2009017161A1 Inhibitory agent for inflammatory cytokine |
| 02/05/2009 | WO2009016691A1 Cancer associated gene ly6k |
| 02/05/2009 | WO2009016651A1 Simplified means for obtaining prn from bordetella pertussis |
| 02/05/2009 | WO2009016456A2 Idiotypic vaccine |
| 02/05/2009 | WO2009016178A1 Methods and substances for the treatment of alzheimer's |
| 02/05/2009 | WO2009016164A1 Novel antibodies |
| 02/05/2009 | WO2009015908A2 Anti ephb4 antibodies and antibody fragments |
| 02/05/2009 | WO2009015846A1 Upregulation of rack-1 in melanoma and its use as a marker |
| 02/05/2009 | WO2009015843A1 Novel immunotherapy against neuronal and brain tumors |
| 02/05/2009 | WO2009015842A2 Novel immunogenic epitopes for immunotherapy |
| 02/05/2009 | WO2009015841A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | WO2008150814A3 Methods for production and uses of multipotent cell populations |
| 02/05/2009 | WO2008144485A3 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity |
| 02/05/2009 | WO2008144019A3 Suppression of allergic inflammation by ascaris heme-binding protein (hbp) |
| 02/05/2009 | WO2008140812A3 Compositions and methods comprising klk3, psca, or folh1 antigen |
| 02/05/2009 | WO2008140602A3 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN |
| 02/05/2009 | WO2008140493A9 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
| 02/05/2009 | WO2008131376A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 02/05/2009 | WO2008130381A3 Polyglutamic acid compositions and their use as immunogens |
| 02/05/2009 | WO2008122551A9 Anti-epcam antibody and uses thereof |
| 02/05/2009 | WO2008108986A3 Methods and compositions for treating tumor diseases |
| 02/05/2009 | WO2008054606A3 High affinity human antibodies to human il-4 receptor |
| 02/05/2009 | WO2008036341A3 Compositions and methods relating to glucagon receptor antibodies |
| 02/05/2009 | WO2007144647A3 Adjuvant compositions |
| 02/05/2009 | WO2007103042A3 Mycoplasma hyopneumoniae vaccine |
| 02/05/2009 | WO2006120678A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 02/05/2009 | WO2005000193A3 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 02/05/2009 | WO2004075855A3 Process for in vivo treatment of specific biological targets in bodily fluid |
| 02/05/2009 | US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 02/05/2009 | US20090035837 Virus Production |
| 02/05/2009 | US20090035753 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 02/05/2009 | US20090035360 Lyophilised antigen composition |
| 02/05/2009 | US20090035359 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 02/05/2009 | US20090035350 Polymers for implantable devices exhibiting shape-memory effects |
| 02/05/2009 | US20090035331 Systems and Methods for Targeted and Controlled Delivery of Agents |
| 02/05/2009 | US20090035330 Vaccine Composition Comprising B-Subunit Of E. coli Heat Toxin And An Antigen And An Adjuvant |
| 02/05/2009 | US20090035329 Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions |
| 02/05/2009 | US20090035328 fHbp- AND LPXL1-BASED VESICLE VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS |
| 02/05/2009 | US20090035327 Antibody Gene Transfer and Recombinant AAV Therefor |
| 02/05/2009 | US20090035326 Compositions with antigens adsorbed to calcium phosphate |
| 02/05/2009 | US20090035325 Canine influenza virus and related compositions and methods of use |
| 02/05/2009 | US20090035324 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections |
| 02/05/2009 | US20090035323 Immune response modifier conjugates |
| 02/05/2009 | US20090035322 Human Antibodies to Human CD20 and Method of Using Thereof |
| 02/05/2009 | US20090035321 Intercellular adhesion molecules and their binding ligands |
| 02/05/2009 | US20090035320 Agents for Regulating Liver Regeneration/Repair |
| 02/05/2009 | US20090035319 Antibodies Against C3a Receptor |
| 02/05/2009 | US20090035318 Method and composition for increasing the engraftment efficiency of stem cells |
| 02/05/2009 | US20090035317 Peptides binding to vascular endothelial growth factor |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035315 Method of Improving Treatments in Rheumatic and Arthritic Diseases |
| 02/05/2009 | US20090035314 Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 02/05/2009 | US20090035313 Compounds |
| 02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
| 02/05/2009 | US20090035311 Identification and use of prognostic and predictive markers in cancer treatment |
| 02/05/2009 | US20090035310 Cancer treatment |
| 02/05/2009 | US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase |
| 02/05/2009 | US20090035308 Methods for using and identifying modulators of Delta-like 4 |
| 02/05/2009 | US20090035307 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 02/05/2009 | US20090035306 Quinazolinone modulators of tgr5 |
| 02/05/2009 | US20090035305 Compositions and Methods for Treating Viral Infection |
| 02/05/2009 | US20090035304 Use of Tgf-beta Antagonists to Limit Nephrotoxicity of Immunosuppressive Agents |
| 02/05/2009 | US20090035303 Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators |
| 02/05/2009 | US20090035302 Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith |
| 02/05/2009 | US20090035301 Methods for diagnosing and treating bladder cancer |
| 02/05/2009 | US20090035300 Immunomodulation of dendritic cells |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035298 Methods to treat alzheimer's disease or other amyloid beta accumulation associated disorders |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035295 Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies |
| 02/05/2009 | US20090035281 Combination of interleukin-6 antagonists and antiproliferative drugs |
| 02/05/2009 | US20090035274 Treatment and/or prevention of cancer and/or arthritis |
| 02/05/2009 | US20090035270 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha |
| 02/05/2009 | US20090035269 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035265 Compositions and Methods for Targeted Delivery of Factors |
| 02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
| 02/05/2009 | US20090035260 Enhanced nasal composition of active peptide |
| 02/05/2009 | US20090035259 Group a streptococcal vaccines |
| 02/05/2009 | US20090035253 Poly(lactide-Co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/05/2009 | US20090035252 Method of inducing a CTL response |
| 02/05/2009 | US20090035217 Truncated Fragments of Alpha-Synuclein in Lewy Body Disease |
| 02/05/2009 | US20090035216 Method for determining in vivo biopharmaceutical concentration or bioavailability |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2695199A1 Human antibodies to human cd20 and method of using thereof |
| 02/05/2009 | CA2695169A1 Compositions comprising pneumococcal antigens |
| 02/05/2009 | CA2695060A1 Upregulation of rack-1 in melanoma and its use as a marker |
| 02/05/2009 | CA2694808A1 Novel immunotherapy against neuronal and brain tumors |
| 02/05/2009 | CA2694805A1 Immunogenic epitopes of tumour-associated antigens |
| 02/05/2009 | CA2694771A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2694762A1 Methods and compositions for increasing alpha-l-iduronidase activity in the cns |
| 02/05/2009 | CA2694646A1 Combinations of mek inhibitors and raf kinase inhibitors and uses thereof |